GC Biopharma녹십자
006280 · KOSPI · ₩006280 · 녹십자
₩132,000▲ ₩1,500 (1.15%)End-of-day · Oct 29, 2026 · End-of-day prices.
Filings
- Major management matter relevant to investors투자판단관련주요경영사항Oct 30, 2026Open on DART
Predicted impact: Low
Administrative lawsuit loss and constitutional complaint already reported; filing title gives no new detail.
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 7, 2026Open on DART
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Jul 31, 2026Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Jul 31, 2026Open on DART
- New Facility Investment, etc.신규시설투자등Jul 16, 2026Open on DART
- [Amended Filing] Major Matters Report (Decision on Transfer of Equity Securities of Another Company)[기재정정]주요사항보고서(타법인주식및출자증권양도결정)Jul 10, 2026Open on DART
- [Amended Filing] Major Matters Report (Decision on Transfer of Equity Securities of Another Company)[기재정정]주요사항보고서(타법인주식및출자증권양도결정)Jul 9, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Jul 1, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jul 1, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Jun 22, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 22, 2026Open on DART
- Disclosure of Corporate Governance Report기업지배구조보고서공시Jun 1, 2026Open on DART
- Major Matters Report (Decision on Transfer of Equity Securities of Another Company)주요사항보고서(타법인주식및출자증권양도결정)May 27, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서May 11, 2026Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)May 8, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항May 6, 2026Open on DART
- Sale of shares in another company타법인주식및출자증권처분결정Mar 31, 2026Open on DART
- Amended: Annual general meeting results[기재정정]정기주주총회결과Mar 31, 2026Open on DART
- Change in largest shareholder's holdings최대주주등소유주식변동신고서Mar 27, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 26, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 25, 2026Open on DART
- Audit report submitted감사보고서제출Mar 18, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Securities Issuance Results Report증권발행실적보고서Mar 11, 2026Open on DART
- Prospectus투자설명서Mar 11, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최(안내공시)Mar 10, 2026Open on DART
- Terms set: Securities registration statement[발행조건확정]증권신고서(채무증권)Mar 10, 2026Open on DART
- Amended: Change in revenue or profit of 30% or more[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변경Mar 9, 2026Open on DART
- Amended: Shareholders' meeting called[기재정정]주주총회소집결의Mar 6, 2026Open on DART
- Terms set: Securities registration statement[발행조건확정]증권신고서(채무증권)Mar 5, 2026Open on DART
- Amended: Securities registration statement[기재정정]증권신고서(채무증권)Mar 5, 2026Open on DART
- Securities registration statement증권신고서(채무증권)Feb 26, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Feb 11, 2026Open on DART
- Cash dividend decision현금ㆍ현물배당결정Feb 11, 2026Open on DART
- Shareholder Register Closure for Cash/Stock Dividend (Record Date) Decision현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Feb 11, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항Feb 5, 2026Open on DART
- Fair Trade Self-Compliance Program Operation Status (Informational Disclosure)공정거래자율준수프로그램운영현황(안내공시)Jan 30, 2026Open on DART
- Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Jan 26, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 7, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jan 2, 2026Open on DART
- Other management matters기타경영사항(자율공시) (배당기준일 변경 안내)Dec 16, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2025Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Dec 16, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Nov 3, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: GC Biopharma / 녹십자 / 006280 / KRX:006280
Source: KRX statistical information